Latest Breaking News On - Puma biotechnology inc - Page 1 : comparemela.com

StockNews com Upgrades Puma Biotechnology (NASDAQ:PBYI) to Buy

Puma Biotechnology (NASDAQ:PBYI – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a report released on Wednesday. Separately, HC Wainwright restated a “buy” rating and issued a $7.00 price objective on shares of Puma Biotechnology in a report on Monday, June 3rd. Read Our […]

United statesPuma biotechnology incAcadian asset managementCapital partnersGreat point partnersCitigroup incPuma biotechnologyGet free reportAsset managementPoint partnersPuma biotechnology daily

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesCompensation committee of puma board directorsEuropean commissionPuma biotechnology incDrug administrationPuma biotechnologyCompensation committeeInducement incentive award planNasdaq listing rule

LA500 2024: Alan Auerbach

LA500 2024: Alan Auerbach
labusinessjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from labusinessjournal.com Daily Mail and Mail on Sunday newspapers.

Poet societyCougar biotechnology incPuma biotechnology incChief executivePuma biotechnology

Puma Biotechnology to Join Russell 3000 Index

Puma Biotechnology to Join Russell 3000 Index
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesAlanh auerbachExchange commissionDrug administrationEuropean commissionPuma biotechnology incPuma biotechnologyRussell investmentRussell indexesChief executive officerRussell globalLooking statementsAnnual report

Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting

Puma Biotechnology, Inc. , a biopharmaceutical company, announced the release of abstracts on alisertib to be presented at the 2024 American Society of Clinical Oncology Annual Meeting. The ASCO.

United statesSan franciscoMccormick placeKarthik giridharTurja chakrabartiAmerican society of clinical oncologyPuma biotechnology incUniversity of californiaPuma biotechnologyClinical oncologyMayo clinicDrug administrationEuropean commission